Mihoko Saito-Adachi

Mihoko Saito-Adachi

Auto-generated profile, based on publicly available information

Mihoko Saito-Adachi

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
SYShinichi Yachida
Shinichi Yachida
YTYasushi Totoki
Yasushi Totoki
MNMichaël Noë
Michaël Noë
YNYoichiro Nakatani
Yoichiro Nakatani
MHMasafumi Horie
Masafumi Horie
TSTatsuhiro Shibata
Tatsuhiro Shibata
The neuroendocrine carcinoma of the gastrointestinal system (GIS-NEC) is a rare but highly malignant neoplasm. We analyzed 115 cases using whole-genome/exome sequencing, transcriptome sequencing, DNA methylation assays, and/or ATAC-seq and found GIS-NECs to be genetically distinct from neuroendocrine tumors (GIS-NET) in the same location. Clear genomic differences were also evident between pancreatic NECs (Panc-NEC) and nonpancreatic GIS-NECs (Nonpanc-NEC). Panc-NECs could be classified into two subgroups (i.e., “ductal-type” and “acinar-type”) based on genomic features. Alterations in TP53 and RB1 proved common in GIS-NECs, and most Nonpanc-NECs with intact RB1 demonstrated mutually exclusive amplification of CCNE1 or MYC. Alterations of the Notch gene family were characteristic of Nonpanc-NECs. Transcription factors for neuroendocrine differentiation, especially the SOX2 gene, appeared overexpressed in most GIS-NECs due to hypermethylation of the promoter region. This first comprehensive study of genomic alterations in GIS-NECs uncovered several key biological processes underlying genesis of this very lethal form of cancer. Significance: GIS-NECs are genetically distinct from GIS-NETs. GIS-NECs arising in different organs show similar histopathologic features and share some genomic features, but considerable differences exist between Panc-NECs and Nonpanc-NECs. In addition, Panc-NECs could be classified into two subgroups (i.e., “ductal-type” and “acinar-type”) based on genomic and epigenomic features. This article is highlighted in the In This Issue feature, p. 587

13 March 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YTYasushi Totoki
Yasushi Totoki
MSMihoko Saito-Adachi
Mihoko Saito-Adachi
YSYuichi Shiraishi
Yuichi Shiraishi
DKDaisuke Komura
Daisuke Komura
HNHiromi Nakamura
Hiromi Nakamura
TSTatsuhiro Shibata
Tatsuhiro Shibata

16 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AFAkihiko Fukagawa
Akihiko Fukagawa
NHNatsuko Hama
Natsuko Hama
YTYasushi Totoki
Yasushi Totoki
HNHiromi Nakamura
Hiromi Nakamura
YAYasuhito Arai
Yasuhito Arai
TSTatsuhiro Shibata
Tatsuhiro Shibata
Renal cell carcinoma (RCC) comprises several histological types characterised by different genomic and epigenomic aberrations; however, the molecular pathogenesis of each type still requires further exploration. We perform whole-genome sequencing of 128 Japanese RCC cases of different histology to elucidate the significant somatic alterations and mutagenesis processes. We also perform transcriptomic and epigenomic sequencing to identify distinguishing features, including assay for transposase-accessible chromatin sequencing (ATAC-seq) and methyl sequencing. Genomic analysis reveals that the mutational signature differs among the histological types, suggesting that different carcinogenic factors drive each histology. From the ATAC-seq results, master transcription factors are identified for each histology. Furthermore, clear cell RCC is classified into three epi-subtypes, one of which expresses highly immune checkpoint molecules with frequent loss of chromosome 14q. These genomic and epigenomic features may lead to the development of effective therapeutic strategies for RCC.

22 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMihoko Saito-Adachi
Mihoko Saito-Adachi
NHNatsuko Hama
Natsuko Hama
YTYasushi Totoki
Yasushi Totoki
HNHiromi Nakamura
Hiromi Nakamura
YAYasuhito Arai
Yasuhito Arai
TSTatsuhiro Shibata
Tatsuhiro Shibata
Structural variants (SVs) are responsible for driver events in gastric cancer (GC); however, their patterns and processes remain poorly understood. Here, we examine 170 GC whole genomes to unravel the oncogenic structural aberration landscape in GC genomes and identify six rearrangement signatures (RSs). Non-random combinations of RSs elucidate distinctive GC subtypes comprising one or a few dominant RS that are associated with specific driver events (BRCA1/2 defects, mismatch repair deficiency, and TP53 mutation) and epidemiological backgrounds. Twenty-seven SV hotspots are identified as GC driver candidates. SV hotspots frequently constitute complexly clustered SVs involved in driver gene amplification, such as ERBB2, CCNE1, and FGFR2. Further deconstruction of the locally clustered SVs uncovers amplicon-generating profiles characterized by super-large SVs and intensive segmental amplifications, contributing to the extensive amplification of GC oncogenes. Comprehensive analyses using adjusted SV allele frequencies indicate the significant involvement of extra-chromosomal DNA in processes linked to specific RSs.

2 September 2024 in Research Square
Verified
Preprint
Open access
PDF file
TSTatsuhiro Shibata
Tatsuhiro Shibata
SSSatoshi Shiba
Satoshi Shiba
SYShinichi Yachida
Shinichi Yachida
SMSayaka Mizutani
Sayaka Mizutani
YTYasushi Totoki
Yasushi Totoki
TYTakuji Yamada
Takuji Yamada
The recent rapid increase in colorectal cancer (CRC) cases, particularly among young patients, poses a significant public health concern in Japan and other countries. The association between the gut microbiota and CRC has been well established. Here, we present a detailed analysis of this association by combining whole-genome sequencing (WGS) and whole-transcriptome data from CRC tissues with whole-genome metagenomic sequencing (WGMS) of fecal samples. The utilization of explanatory artificial intelligence analysis enabled classification of the disease into four distinct subtypes. This microbiome-based subclassification was found to be correlated with specific clinical and molecular characteristics, and included a subgroup having a higher proportion of younger patients with an unfavorable prognosis. The WGS analysis revealed mutational signatures (SBS88 and ID18) associated with colibactin exposure; these were considered early clonal events and found in 70.3% of patients (97 out of 138), with higher prevalence in the younger subtype. APC hotspot mutation and frameshift deletion, which matched the colibactin signature and the colibactin-specific motif, were observed in 12 patients (8.7%). CRCs exhibiting colibactin-associated mutational signatures were more common in younger patients and had an immunosuppressive microenvironment. Colibactin exposure is a highly prevalent but modifiable risk factor for CRC in the Japanese population.

10 August 2026 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SSSatoshi Shiba
Satoshi Shiba
SYShinichi Yachida
Shinichi Yachida
SMSayaka Mizutani
Sayaka Mizutani
YTYasushi Totoki
Yasushi Totoki
HNHiromi Nakamura
Hiromi Nakamura
TSTatsuhiro Shibata
Tatsuhiro Shibata
The incidence of colorectal cancer (CRC) has risen in recent decades, with a disproportionate increase observed among younger individuals in Japan and other countries. The etiological contribution of the gut microbiota to CRC pathogenesis is recognized, yet the mechanisms involved remain to be fully clarified. Here we integrated whole-genome sequencing (WGS) and transcriptome profiling of CRC with whole-genome metagenomic sequencing of fecal samples to interrogate host–microbiome interactions at high resolution. Application of interpretable artificial intelligence enabled the stratification of CRC into four distinct microbiome-informed subtypes. WGS analysis identified mutational signatures SBS88 and ID18, linked to colibactin exposure, as early clonal events detected in 44.8% of non-hypermutated patients. Notably, these signatures were significantly more frequent among patients born after the 1960s. Microbiome-based subclassification revealed subtype-specific clinical and molecular features. Collectively, our findings indicate that colibactin exposure constitutes a prevalent and potentially modifiable risk factor for CRC in the Japanese population.